Why the study?
Catheter-based slow-pathway modification is the treatment of choice for symptomatic AVNRT, but the interactions between patient age and procedural outcomes in pediatric patients remained unclear.
Does patient age impact AVNRT recurrence in pediatric patients undergoing catheter-based slow-pathway modification?
Does patient age impact AVNRT recurrence in pediatric patients undergoing catheter-based slow-pathway modification?
Radiofrequency slow-pathway modification is highly effective and safe for pediatric AVNRT across age groups, with the youngest patients not facing a higher risk of recurrence.
Answers are grounded in this paper and cite their sources.
Supports safety of slow-pathway modification across pediatric ages; leaves open prospective confirmation of age-independent outcomes.
Background Catheter‐based slow‐pathway modification (SPM) is the treatment of choice for symptomatic atrioventricular nodal reentrant tachycardia (AVNRT). We sought to investigate the interactions between patient age and procedural outcomes in pediatric patients undergoing catheter‐based SPM for AVNRT. Methods and Results A retrospective cohort study was performed, including consecutive patients undergoing acutely successful SPM for AVNRT from 2008 to 2017. Those with congenital heart disease, cardiomyopathy, and accessory pathways were excluded. Patients were stratified by age quartile at time of SPM. The primary outcome was AVNRT recurrence. A total of 512 patients underwent successful SPM for AVNRT. Age quartile 1 had 129 patients with a median age and weight of 8.9 years and 30.6 kg, respectively. Radiofrequency energy was used in 98% of cases. Follow‐up was available in 447 (87%) patients with a median duration of 0.8 years (interquartile range, 0.2–2.5 years). AVNRT recurred in 22 patients. Multivariable Cox proportional hazard modeling identified atypical AVNRT (hazard ratio [HR], 5.83; 95% CI, 2.01–16.96; P =0.001), dual atrioventricular nodal only (HR, 4.09; 95% CI, 1.39–12.02; P =0.011), total radiofrequency lesions (HR, 1.06 per lesion; 95% CI, 1.01–1.12; P =0.032), and the use of a long sheath (HR, 3.52; 95% CI, 1.23–10.03; P =0.010) as predictors of AVNRT recurrence; quartile 1 patients were not at higher risk of recurrence (HR, 0.45; 95% CI, 0.10–1.97; P =0.29). Complete heart block requiring permanent pacing occurred in one quartile 2 patient at 14.9 years of age. Conclusions Pediatric AVNRT can be treated with radiofrequency‐SPM with high procedural efficacy and minimal risk of complications, including heart block. Atypical AVNRT and dual atrioventricular nodal physiology without inducible tachycardia remain challenging substrates.
No takes yet. Share an insight, caveat, or question.
O’Leary et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: